关键词：静脉内疗法；药物；营养物；最快路线
摘 要：The Global Intravenous Solutions market has been experiencing steady growth for the past few years. Most of the growth in the global market in 2013 stems from the Americas and the EMEA region, and both of these regions together account for approximately 90 percent of the market share. The APAC region is expected to grow at a faster pace owing to the rapid adoption of intravenous solutions and the increasing awareness among the global population about benefits offered by intravenous solutions. The overall market is expected to grow at a CAGR of 7.88 percent during the forecast period.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Geographical Segmentation

07.1 Intravenous Solutions Market in the Americas

07.1.1 Market Size and Forecast

07.2 Intravenous Solutions Market in the EMEA Region

07.2.1 Market Size and Forecast

07.3 Intravenous Solutions Market in the APAC Region

07.3.1 Market Size and Forecast

08. Key Leading Countries

08.1 Key Leading Countries in the Americas

08.1.1 USA

08.2 Key Leading Countries in the EMEA Region

08.2.1 Germany

08.2.2 UK

08.3 Key Leading Countries in the APAC Region

08.3.1 Japan

08.3.2 China

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

16.1 Competitive Scenario

16.1.1 Key News

16.1.2 Mergers and Acquisitions

16.2 Market Share Analysis 2013

16.3 Other Prominent Vendors

17. Key Vendor Analysis

17.1 B. Braun Melsungen AG

17.1.1 Business Overview hbsti00 fro

17.1.2 Business Segmentation

17.1.3 Key Information

17.1.4 SWOT Analysis

17.2 Baxter International Inc.

17.2.1 Business Overview

17.2.2 Business Segmentation

17.2.3 Key Information

17.2.4 SWOT Analysis

17.3 Fresenius Kabi AG

17.3.1 Business Overview

17.3.2 Business Segmentation

17.3.3 Key Information

17.3.4 SWOT Analysis

17.4 Hospira Inc.

17.4.1 Business Overview

17.4.2 Business Segmentation

17.4.3 Key Information

17.4.4 SWOT Analysis

18. Other Reports in this Series